Winner Medical Co Ltd
SZSE:300888
Income Statement
Earnings Waterfall
Winner Medical Co Ltd
Revenue
|
9.7B
CNY
|
Cost of Revenue
|
-5.1B
CNY
|
Gross Profit
|
4.7B
CNY
|
Operating Expenses
|
-3.4B
CNY
|
Operating Income
|
1.2B
CNY
|
Other Expenses
|
1.3B
CNY
|
Net Income
|
2.5B
CNY
|
Income Statement
Winner Medical Co Ltd
Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
10 979
N/A
|
12 534
+14%
|
14 802
+18%
|
12 414
-16%
|
8 831
-29%
|
8 037
-9%
|
8 091
+1%
|
9 135
+13%
|
9 860
+8%
|
11 351
+15%
|
11 381
+0%
|
10 460
-8%
|
9 719
-7%
|
|
Gross Profit | ||||||||||||||
Cost of Revenue |
(4 392)
|
(5 212)
|
(6 237)
|
(5 341)
|
(4 568)
|
(4 121)
|
(4 275)
|
(4 820)
|
(5 133)
|
(6 305)
|
(6 012)
|
(5 498)
|
(5 067)
|
|
Gross Profit |
6 587
N/A
|
7 322
+11%
|
8 565
+17%
|
7 073
-17%
|
4 262
-40%
|
3 916
-8%
|
3 817
-3%
|
4 315
+13%
|
4 727
+10%
|
5 047
+7%
|
5 369
+6%
|
4 962
-8%
|
4 652
-6%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(2 646)
|
(2 507)
|
(3 300)
|
(2 748)
|
(2 193)
|
(2 706)
|
(2 784)
|
(3 018)
|
(3 373)
|
(3 253)
|
(3 602)
|
(3 444)
|
(3 421)
|
|
Selling, General & Administrative |
(2 204)
|
(2 032)
|
(2 601)
|
(2 225)
|
(1 832)
|
(2 212)
|
(2 498)
|
(2 603)
|
(2 867)
|
(2 460)
|
(2 758)
|
(2 712)
|
(2 747)
|
|
Research & Development |
(385)
|
(387)
|
(511)
|
(432)
|
(341)
|
(283)
|
(293)
|
(347)
|
(401)
|
(467)
|
(504)
|
(444)
|
(382)
|
|
Depreciation & Amortization |
0
|
(157)
|
0
|
0
|
0
|
(314)
|
0
|
0
|
0
|
(408)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(57)
|
69
|
(188)
|
(91)
|
(21)
|
101
|
7
|
(69)
|
(105)
|
81
|
(340)
|
(288)
|
(292)
|
|
Operating Income |
3 941
N/A
|
4 815
+22%
|
5 265
+9%
|
4 325
-18%
|
2 069
-52%
|
1 210
-42%
|
1 032
-15%
|
1 297
+26%
|
1 354
+4%
|
1 793
+32%
|
1 767
-2%
|
1 519
-14%
|
1 231
-19%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(79)
|
(184)
|
(157)
|
(99)
|
39
|
270
|
288
|
315
|
327
|
210
|
235
|
218
|
213
|
|
Non-Reccuring Items |
0
|
(125)
|
0
|
(0)
|
(0)
|
(17)
|
3
|
3
|
2
|
(70)
|
4
|
10
|
1 606
|
|
Total Other Income |
(16)
|
(3)
|
(38)
|
(27)
|
(31)
|
(1)
|
(7)
|
(13)
|
(15)
|
(13)
|
(53)
|
(49)
|
(46)
|
|
Pre-Tax Income |
3 847
N/A
|
4 502
+17%
|
5 070
+13%
|
4 198
-17%
|
2 076
-51%
|
1 463
-30%
|
1 316
-10%
|
1 602
+22%
|
1 668
+4%
|
1 920
+15%
|
1 952
+2%
|
1 697
-13%
|
3 004
+77%
|
|
Net Income | ||||||||||||||
Tax Provision |
(542)
|
(680)
|
(767)
|
(650)
|
(313)
|
(225)
|
(201)
|
(228)
|
(268)
|
(245)
|
(248)
|
(215)
|
(411)
|
|
Income from Continuing Operations |
3 305
|
3 823
|
4 303
|
3 549
|
1 764
|
1 237
|
1 114
|
1 374
|
1 400
|
1 674
|
1 705
|
1 483
|
2 593
|
|
Income to Minority Interest |
(13)
|
(12)
|
(12)
|
(10)
|
1
|
2
|
2
|
(3)
|
(15)
|
(24)
|
(34)
|
(43)
|
(45)
|
|
Net Income (Common) |
3 292
N/A
|
3 810
+16%
|
4 291
+13%
|
3 539
-18%
|
1 764
-50%
|
1 239
-30%
|
1 116
-10%
|
1 371
+23%
|
1 386
+1%
|
1 651
+19%
|
1 670
+1%
|
1 439
-14%
|
2 548
+77%
|
|
EPS (Diluted) |
8.75
N/A
|
9.79
+12%
|
10.05
+3%
|
8.29
-18%
|
4.13
-50%
|
2.08
-50%
|
2.62
+26%
|
3.28
+25%
|
2.35
-28%
|
2.79
+19%
|
2.84
+2%
|
2.43
-14%
|
4.31
+77%
|